Combined Argon Laser and Intravitreal Injections for Proliferative Diabetic Retinopathy (PDR)
Proliferative Diabetic Retinopathy (PDR) Treatment: Combining Argon Laser and Injections to Protect Your Vision
Proliferative Diabetic Retinopathy (PDR) is one of the most serious complications of diabetes affecting the eyes. In PDR, abnormal, fragile new blood vessels develop in the retina, significantly increasing the risk of intraocular hemorrhage and retinal detachment, leading to vision loss. Fortunately, modern medical advancements offer effective treatment protocols, most notably the combination of argon laser sessions and intravitreal injections, which we will discuss in detail in this article.
What is Proliferative Diabetic Retinopathy (PDR)?
When blood sugar levels remain high for extended periods, the tiny blood vessels in the retina begin to damage and leak, leading to oxygen deprivation in parts of the retina. In response to this deficiency, the retina starts to secrete growth factors that stimulate the formation of new blood vessels. These new vessels, known as proliferative vessels, are abnormal, weak, and extend into unusual areas of the retina or even into the vitreous humor. They are the primary cause of serious complications in proliferative diabetic retinopathy.
Why is PDR dangerous?
- Vitreous Hemorrhage: Proliferative vessels are extremely fragile and can easily rupture, causing bleeding into the vitreous humor, which leads to sudden floaters, severe blurred vision, or even complete vision loss if the hemorrhage is dense.
- Retinal Detachment: Proliferative vessels can scar and form a band that pulls on the retina, leading to its detachment from the posterior eye wall. Retinal detachment is an emergency condition that requires immediate surgical intervention to prevent permanent vision loss.
- Neovascular Glaucoma: In some cases, new blood vessels can form in the iris and the angle of the eye, obstructing the drainage of fluid from the eye and significantly raising intraocular pressure, causing damage to the optic nerve.
Combined Treatment Protocol: Argon Laser and Injections
The treatment of proliferative diabetic retinopathy no longer relies on a single method; rather, a combined approach is often the most effective. This approach aims to control the growth of abnormal blood vessels and reduce the risk of complications.
1. Argon Laser Photocoagulation
Retinal laser treatment, specifically argon laser, has been a cornerstone in the treatment of diabetic retinopathy for decades. The laser is used to create small spots on the periphery of the retina, away from the central area responsible for sharp vision (the macula). The purpose of these laser spots is to:
- Reduce oxygen demand: By destroying peripheral retinal areas suffering from oxygen deprivation, the oxygen-deprivation signals that stimulate new vessel growth are reduced.
- Shrink existing vessels: The laser can help shrink the size of already existing proliferative vessels.
- Prevent hemorrhage: By reducing the stimulation of new vessel growth, the laser decreases the risk of vitreous hemorrhage.
Argon laser sessions are typically performed in several stages, and the patient may require multiple sessions to ensure adequate coverage of the affected retinal areas. The cost of retinal laser treatment in Egypt for 2026 is approximately 5,000 EGP (estimated). It should be noted that these prices are approximate and depend on the individual case.
2. Intravitreal Injections
In recent years, intravitreal injections have revolutionized the treatment of retinal diseases, including proliferative diabetic retinopathy. These injections primarily use two types of medications:
- Anti-Vascular Endothelial Growth Factor (Anti-VEGF) agents: Such as Eylea and Vabysmo. These medications work by inhibiting Vascular Endothelial Growth Factor (VEGF), the primary protein responsible for stimulating the growth of abnormal blood vessels and the leakage of fluids from vessels.
- Corticosteroids: Sometimes used, especially in cases with accompanying inflammation or to reduce swelling.
Injections are very effective in:
- Shrinking existing proliferative vessels.
- Preventing the formation of new vessels.
- Reducing the risk of hemorrhage.
- Treating associated Macular Edema, which is swelling in the center of vision that can occur with diabetic retinopathy.
Injections are performed in the doctor's office and are a relatively quick and safe procedure. The patient may require several injections at spaced intervals depending on their response to the treatment. The cost of Intravitreal Injections (IVI) in Egypt for 2026 varies depending on the type of medication used. The price of Eylea / Lucentis injections is approximately 9,000 EGP (estimated), while the price of Vabysmo injections is approximately 11,000 EGP (estimated). These prices are approximate and depend on the condition.
Why is Combination Therapy the Optimal Solution?
In cases of advanced proliferative diabetic retinopathy, combining argon laser and injections is often the most effective strategy for several reasons:
- Synergistic effect: The laser treats the damaged peripheral retinal areas, while injections directly target abnormal vessels and reduce growth factors. This dual effect provides stronger protection for the retina.
- Hemorrhage control: The laser reduces the likelihood of new hemorrhage, while injections help shrink existing vessels and reduce the risk of their rupture.
- Treatment of macular edema: If there is swelling in the center of vision, injections are very effective in treating it, which the laser alone may not achieve.
- Reduced need for surgery: By effectively controlling the disease, this combined approach can reduce the likelihood of needing complex surgeries such as vitrectomy in the future.
When is this combined treatment used?
Each case is individually assessed by a retinal specialist to determine the most appropriate treatment protocol. Generally, combined treatment is considered in the following situations:
- Active proliferative diabetic retinopathy with recent hemorrhage or prominent proliferative vessels.
- Presence of associated macular edema with proliferative diabetic retinopathy.
- Cases that have not responded adequately to laser treatment alone.
- Patients who urgently need to reduce the risk of hemorrhage before undergoing other surgery (such as cataract surgery).
The Role of Dr. Mahmoud Hassan and Al Mashreq Eye Center
At Al Mashreq Eye Center in Cairo, we are committed to providing the latest treatment protocols for diabetic retinopathy, including combined therapy for PDR. As a key contributor to the center, Dr. Mahmoud Hassan and his team meticulously evaluate each case, explain available treatment options, and apply the most effective techniques to ensure the best possible outcomes for our patients. We believe that a clear understanding of the disease and treatment options is the first step towards preserving your vision.
Prevention and Continuous Follow-up
Strict control of blood sugar, blood pressure, and cholesterol levels remains the cornerstone of preventing and managing the progression of diabetic retinopathy. In addition, regular eye examinations, especially for diabetic patients, are essential for early detection of any changes and taking necessary actions before the condition worsens. Regular follow-up with a specialized ophthalmologist, especially after treatment, is crucial to ensure stable condition and prevent relapse.
If you have diabetes and are concerned about your vision, do not hesitate to consult a specialist. You can learn more about retinal surgeries by watching my videos on .
For reservations and inquiries: 01002310813